Oxford BioDynamics Statistics
Total Valuation
Oxford BioDynamics has a market cap or net worth of GBP 13.86 million. The enterprise value is 18.68 million.
Market Cap | 13.86M |
Enterprise Value | 18.68M |
Important Dates
The next estimated earnings date is Tuesday, September 17, 2024.
Earnings Date | Sep 17, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Oxford BioDynamics has 311.86 million shares outstanding. The number of shares has increased by 49.58% in one year.
Shares Outstanding | 311.86M |
Shares Change (YoY) | +49.58% |
Shares Change (QoQ) | +29.80% |
Owned by Insiders (%) | 3.43% |
Owned by Institutions (%) | 68.08% |
Float | 265.35M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 12.90 |
PB Ratio | 5.54 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -1.68 |
EV / Sales | 30.28 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -2.76 |
Financial Position
The company has a current ratio of 0.68, with a Debt / Equity ratio of 370.22.
Current Ratio | 0.68 |
Quick Ratio | 0.62 |
Debt / Equity | 370.22 |
Debt / EBITDA | n/a |
Debt / FCF | -0.89 |
Interest Coverage | -47.51 |
Financial Efficiency
Return on equity (ROE) is -266.70% and return on invested capital (ROIC) is -70.95%.
Return on Equity (ROE) | -266.70% |
Return on Assets (ROA) | -56.23% |
Return on Capital (ROIC) | -70.95% |
Revenue Per Employee | 11,642 |
Profits Per Employee | -209,585 |
Employee Count | 45 |
Asset Turnover | 0.05 |
Inventory Turnover | 1.20 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -61.01% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -61.01% |
50-Day Moving Average | 7.05 |
200-Day Moving Average | 12.58 |
Relative Strength Index (RSI) | 20.72 |
Average Volume (20 Days) | 2,228,075 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Oxford BioDynamics had revenue of GBP 617,000 and -11.11 million in losses. Loss per share was -0.06.
Revenue | 617,000 |
Gross Profit | 256,000 |
Operating Income | -11.40M |
Pretax Income | -11.53M |
Net Income | -11.11M |
EBITDA | -10.74M |
EBIT | -11.40M |
Loss Per Share | -0.06 |
Balance Sheet
The company has 1.19 million in cash and 6.01 million in debt, giving a net cash position of -4.82 million or -0.02 per share.
Cash & Cash Equivalents | 1.19M |
Total Debt | 6.01M |
Net Cash | -4.82M |
Net Cash Per Share | -0.02 |
Equity (Book Value) | 1.62M |
Book Value Per Share | 0.01 |
Working Capital | -1.23M |
Cash Flow
In the last 12 months, operating cash flow was -6.54 million and capital expenditures -224,000, giving a free cash flow of -6.77 million.
Operating Cash Flow | -6.54M |
Capital Expenditures | -224,000 |
Free Cash Flow | -6.77M |
FCF Per Share | -0.02 |
Margins
Gross Margin | 41.49% |
Operating Margin | -1,848.14% |
Pretax Margin | -1,869.37% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | -1,096.60% |
Dividends & Yields
Oxford BioDynamics does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -49.58% |
Shareholder Yield | -49.58% |
Earnings Yield | -139.54% |
FCF Yield | -48.81% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |